Ubs Group Ag Agios Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 114,186 shares of AGIO stock, worth $6.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,186

Previous 69,359 64.63%

Holding current value

$6.14 Million

Previous $2.99 Million 69.67%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $1.85 Million - $2.23 Million	44,827 Added 64.63%	114,186 $5.07 Million
Q2 2024 Aug 13, 2024	SELL	$27.55 - $48.83 $2.8 Million - $4.96 Million	-101,526 Reduced 59.41%	69,359 $2.99 Million
Q1 2024 May 13, 2024	BUY	$21.32 - $34.81 $3.6 Million - $5.88 Million	169,031 Added 9117.1%	170,885 $5 Million
Q4 2023 Feb 09, 2024	SELL	$19.97 - $24.53 $1.17 Million - $1.44 Million	-58,539 Reduced 96.93%	1,854 $41,000
Q3 2023 Nov 09, 2023	SELL	$24.36 - $28.18 $290,005 - $335,482	-11,905 Reduced 16.47%	60,393 $1.49 Million
Q2 2023 Aug 11, 2023	SELL	$21.38 - $29.19 $289,421 - $395,145	-13,537 Reduced 15.77%	72,298 $2.05 Million
Q1 2023 May 12, 2023	SELL	$21.74 - $30.93 $135,875 - $193,312	-6,250 Reduced 6.79%	85,835 $1.97 Million
Q4 2022 Feb 08, 2023	BUY	$24.81 - $31.52 $1.92 Million - $2.44 Million	77,425 Added 528.14%	92,085 $2.59 Million
Q3 2022 Nov 10, 2022	SELL	$19.51 - $34.14 $1.26 Million - $2.2 Million	-64,475 Reduced 81.47%	14,660 $415,000
Q2 2022 Aug 10, 2022	BUY	$17.06 - $31.42 $567,620 - $1.05 Million	33,272 Added 72.55%	79,135 $1.76 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $3.72 Million - $4.86 Million	-139,562 Reduced 75.27%	45,863 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $2.71 Million - $4.56 Million	91,504 Added 97.43%	185,425 $6.1 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $3.41 Million - $4.74 Million	81,455 Added 653.42%	93,921 $4.34 Million
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $722,124 - $849,876	-13,871 Reduced 52.67%	12,466 $687,000
Q1 2021 May 12, 2021	BUY	$44.23 - $57.5 $1.11 Million - $1.45 Million	25,132 Added 2085.64%	26,337 $1.36 Million
Q4 2020 Feb 11, 2021	BUY	$33.21 - $46.54 $33,043 - $46,307	995 Added 473.81%	1,205 $52,000
Q3 2020 Nov 12, 2020	SELL	$33.87 - $55.93 $87,960 - $145,250	-2,597 Reduced 92.52%	210 $7,000
Q2 2020 Jul 31, 2020	SELL	$34.45 - $53.48 $25,320 - $39,307	-735 Reduced 20.75%	2,807 $150,000
Q1 2020 May 01, 2020	BUY	$31.52 - $53.81 $44,537 - $76,033	1,413 Added 66.37%	3,542 $126,000
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $1.63 Million - $2.75 Million	-54,309 Reduced 96.23%	2,129 $102,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $1.65 Million - $2.52 Million	50,819 Added 904.41%	56,438 $1.83 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $47,093 - $69,462	1,020 Added 22.18%	5,619 $280,000
Q1 2019 May 14, 2019	SELL	$45.92 - $67.67 $2.6 Million - $3.83 Million	-56,671 Reduced 92.49%	4,599 $310,000
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $1.55 Million - $2.78 Million	36,387 Added 146.23%	61,270 $2.83 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $1.23 Million - $1.58 Million	17,204 Added 224.04%	24,883 $1.92 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $5.85 Million - $7.96 Million	-79,963 Reduced 91.24%	7,679 $647,000
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $3.5 Million - $5.06 Million	58,486 Added 200.6%	87,642 $7.17 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $1.05 Million - $1.45 Million	-20,101 Reduced 40.81%	29,156 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $594,458 - $726,909	10,830 Added 28.18%	49,257 $3.29 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,112 Added 790.54%	38,427 $1.98 Million
Q1 2017 Nov 14, 2017	BUY	N/A	4,315	4,315 $252,000

Others Institutions Holding AGIO

# of Institutions

234

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.95B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account